Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$41,040,722
+$9,475,529 QoQ
Shares Held
163,093
+12.4% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#416
of 4,167 holders
Holding Since
Jun 2020
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Employees Provident Fund Board holds $1,255,262,333 across 8 Drug Manufacturers - General names. ABBV ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
518,259 | $621,615,444 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,640,333 | $209,755,987 | |
| 3 | BIIB |
Biogen Inc.
|
704,196 | $152,148,587 | |
| 4 | MRK |
Merck & Co., Inc.
|
535,502 | $68,812,007 | |
| 5 | JNJ |
Johnson & Johnson
|
266,023 | $67,561,861 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
488,657 | $61,736,925 | |
| 7 | ABBV |
AbbVie Inc.
This page
|
163,093 | $41,040,722 | |
| 8 | AMGN |
Amgen Inc
|
90,000 | $32,590,800 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,040,722 | 163,093 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $31,565,193 | 145,134 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $33,131,050 | 145,000 | Shares | Sole | 2026-03-03 | |
| 2025-09-30 | $33,573,300 | 145,000 | Shares | Sole | 2026-03-17 | |
| 2025-06-30 | $24,138,767 | 130,044 | Shares | Sole | 2026-03-17 | |
| 2025-03-31 | $21,266,280 | 101,500 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $7,641,100 | 43,000 | Shares | Sole | 2026-03-17 | |
| 2024-09-30 | $9,874,000 | 50,000 | Shares | Sole | 2026-03-17 | |
| 2024-06-30 | $8,576,000 | 50,000 | Shares | Sole | 2026-03-18 | |
| 2024-03-31 | $8,740,800 | 48,000 | Shares | Sole | 2026-03-18 | |
| 2023-12-31 | $7,810,488 | 50,400 | Shares | Sole | 2026-03-18 | |
| 2023-09-30 | $7,303,940 | 49,000 | Shares | Sole | 2026-03-18 | |
| 2023-06-30 | $6,595,033 | 48,950 | Shares | Sole | 2026-03-31 | |
| 2020-12-31 | $3,905,617 | 36,450 | Shares | Sole | 2026-03-18 | |
| 2020-09-30 | $3,192,655 | 36,450 | Shares | Sole | 2026-03-20 | |
| 2020-06-30 | $3,808,304 | 38,789 | Shares | Sole | 2026-03-31 | |
| No filing history on record for this holder in this stock. | ||||||